Voyageur Pharmaceuticals Ltd.
VYYRF · OTC
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Market Cap | $20 | $22 | $24 | $0 |
| - Cash | $1 | $0 | $1 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $19 | $22 | $23 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -3,346.4% | – | – | – |
| EBITDA | -$1 | -$1 | -$1 | -$0 |
| % Margin | -11,816.2% | – | – | – |
| Net Income | -$1 | -$1 | -$1 | -$0 |
| % Margin | -11,818.8% | – | – | – |
| EPS Diluted | -0.006 | -0.003 | -0.005 | -0.003 |
| % Growth | -67.6% | 35.8% | -60.6% | – |
| Operating Cash Flow | -$1 | -$0 | -$1 | $0 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$1 | -$0 | -$1 | $0 |